Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PFI-2

PFI-2 ((R) -PFI-2 hydrochloride) hydrochloride, a chemical probe, is a potent and selective SET domain containing lysine methyltransferase 7 (SETD7) inhibitor. (R) -PFI-2 shows high inhibiting activity with IC50 value of 2.0 nM and (S) -PFI-2 shows inhibiting activity with IC50 value of 1.0 μM. PFI-2 hydrochloride can be used for the research of chronic kidney disease and inflammation response in the development of renal fibrosis[1][2].

Product Specifications

CAS Number

[1627676-59-8]

Product Name Alternative

(R) -PFI-2

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Histone Methyltransferase

Type

Reference compound

Related Pathways

Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer; Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/PFI-2.html

Purity

99.68

Solubility

DMSO : ≥ 100 mg/mL

Smiles

O=S(C1=CC2=C(CNCC2)C(F)=C1)(N[C@H](CC3=CC=CC(C(F)(F)F)=C3)C(N4CCCC4)=O)=O

Molecular Formula

C23H25F4N3O3S

Molecular Weight

499.52

Precautions

H302, H315, H319, H335

References & Citations

[1]Yuzhen Niu, et al. Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis. Sci Rep. 2017 Apr 18;7:46547.|[2]Benquan Liu, et al. Pharmacological inhibition of SETD7 by PFI-2 attenuates renal fibrosis following folic acid and obstruction injury. Eur J Pharmacol. 2021 Jun 15;901:174097.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

SETD7/KMT7

Citation 01

Acta Pharmacol Sin. 2022 Feb;43 (2) :457-469.|Biochem Pharmacol. 2024 Jan:219:115964.|Med Oncol. 2023 Apr 12;40 (5) :146.|Patent. US20180263995A1.|Sci Adv. 2023 May 26;9 (21) :eade4186.|Sci Total Environ. 2022 Dec 5;861:160682.|Diabetes. 2025 Jun 1;74 (6) :969-982.|Diabetes. 2025 Oct 1;74 (10) :1825-1838.|Int J Mol Med. 2021 Dec;48 (6) :210.|Mol Carcinog. 2023 Aug;62 (8) :1119-1135.|Proc Natl Acad Sci U S A. 2019 Feb 19;116 (8) :2961-2966. |Research Square Print. September 20th, 2022.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

PB1 Recombinant Antibody, PE Conjugated
bsm-61815R-PE-01 20 µL

PB1 Recombinant Antibody, PE Conjugated

Ask
View Details
PB1 Recombinant Antibody, PE Conjugated
bsm-61815R-PE-02 100 µL

PB1 Recombinant Antibody, PE Conjugated

Ask
View Details
Fgf1 Antibody, Biotin conjugated
A21880-50UG 50 µg

Fgf1 Antibody, Biotin conjugated

Ask
View Details
Human ZNF229 shRNA Plasmid
abx955263-01 150 µg

Human ZNF229 shRNA Plasmid

Ask
View Details
Human ZNF229 shRNA Plasmid
abx955263-02 300 µg

Human ZNF229 shRNA Plasmid

Ask
View Details
APC-Linked Polyclonal Antibody to Low Density Lipoprotein Receptor Related Protein 5 (LRP5)
MBS2070047-01 0.1 mL

APC-Linked Polyclonal Antibody to Low Density Lipoprotein Receptor Related Protein 5 (LRP5)

Ask
View Details